Moderna to reduce 10 % of the workforce amid sales of Covid vaccine

accident She said on Thursday that she plans to reduce approximately 10 % of the global workforce by the end of the year, as Kofid launched sales Continue to diminish The company is struggling with uncertainty in the vaccine market.

in note For employees, CEO of Moderna Stephen Bansil said that the company expects to have less than 5,000 workers by the end of the year. Moderna had approximately 5,800 full -time employees in 18 countries as of December 31, 2024, according to it. 2024 annual report.

Midena shares have decreased more than 20 % this year. In May, the company reported sales of vaccine in the first quarter that missed Wall Street estimates. Moderna also moves Politics obstacles Under the Minister of Health and Humanitarian Services, Robert F. Kennedy Junior, who has taken steps to change vaccine guidelines and may threaten access to bullets in the United States

Also in May, Moderna said it would reduce the annual operating expenses by about $ 1.5 billion by 2027. This goal adds to the discounts that It was previously announced.

Moderna will provide another update on her business when she publishes quarterly results on Friday morning.

In the noteand Bansel said that Moderna has made great progress towards discounts by reducing research and development, especially as it concludes experiments on respiratory products, re -negotiating suppliers agreements and reduces manufacturing costs.

“Every effort has been made to avoid affecting jobs,” he said. “But today, the restructuring of our operating structure and the alignment of our cost structure with our business facts is necessary to stay concentrated and financially disciplined, while continuing to invest in our science on the road until 2027.”

He said that “the future of Moderna is bright,” noting that it now contains three approved products and the possibility of up to eight others in the next three years. In May, Food and Drug Administration consent The third Moderna product is ever, a coffeed shot of the next generation.

But Bansel said, “This decision was not taken lightly.”

“It affects teammates and friends who devoted themselves to our mission and who helped build Moderna,” he said. “I want to express, on behalf of the entire Executive Committee and on behalf of the patients whom I served, we thanked all that I contributed to.”